Cyclin D1 expression in oral squamous cell carcinomas: Clinicopathological relevance and correlation with p53 expression

Journal of Oral Pathology and Medicine

Volumn 29, Issue 4, 2000, Pages 167-172

  Lam, King Y ^a   Ng, Irene O L ^a   Yuen, Anthony P W ^a   Kwong, Dora L W ^a   Wei, William ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cyclin D1; Oral; p53; Squamous cell carcinoma

Indexed keywords

CYCLIN D1; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CHI SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GINGIVA TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; JAW TUMOR; MALE; MIDDLE AGED; MOUTH; MOUTH TUMOR; OROPHARYNX TUMOR; PATHOLOGY; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GINGIVAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH FLOOR; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PALATAL NEOPLASMS; SEX FACTORS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034024114     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2000.290404.x     Document Type: Article

References (28)

1. Hunter T, Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-82.
2. Chen X, Bargonetti J, Prives C. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 1995; 55: 4257-63.
3. Lam KY, Tsao SW, Zhang D, et al. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients. Int J Cancer 1997; 74: 212-19.
4. Sarbia M, Stahl M, Fink U, et al. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer 1999; 84: 86-91.
5. Chiesa F, Tradati N, Mauri S, et al. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice. Anticancer Res 1998; 18: 4769-76.
6. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994; 74: 152-58.
7. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993; 119: 1238-43.
8. Nogueira CP, Dolan RW, Gooey J, et al. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope 1998; 108: 345-50.
9. Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A, Ogoshi S. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 1998; 77: 92-7.
10. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 1996; 78: 390-5.
11. Pignataro L, Pruneri G, Carboni N, et al. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 1998; 16: 3069-77.
12. Michalides R, van-Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995; 55: 975-8.
13. Monden N, Nishizaki K, Fukushima K, Masuda Y, Tsukuda K, Shimizu K. Quantitative analysis of cyclin D1 messenger RNA expression in head and neck squamous cell carcinomas. Jpn J Cancer Res 1997; 88: 660-8.
14. Akervall JA, Michalides RJ, Mineta H, et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997; 79: 380-9.
15. Xu J, Gimenez-Conti IB, Cunningham JE, et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998; 83: 204-12.
16. Staibano S, Mignogna MD, Lo Muzio L, et al. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol 1998; 29: 1189-94.
17. Takes RP, Baatenburg-de-Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van-Krieken JH. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res 1998; 18: 4793-800.
18. van Oijen MG. Tilanus MG, Medema RH, Slootweg PJ. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 1998; 27: 367-75.
19. Schoelch ML, Regezi JA, Dekker NP, et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 1999; 35: 333-42.
20. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. World Health Organization international histological classification of tumours: histological typing of cancer and precancer of the oral mucosa. International Histological Classification. Berlin: Springer, 1971: 11-3.
21. Fleming I, Cooper JS, Henson DE, et al. AJCC cancer staging manual. Philadelphia: Lippincott-Raven, 1997: 24-39.
22. Ng IOL, Lam KY, Ng M, Regezi JA. Expression of p21/waf1 in oral squamous cell carcinomas - correlation with p53 and mdm2 and cellular proliferative index. Oral Oncol 1999; 35: 63-9.
23. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 1998; 18: 4779-86.
24. Davidson BJ, Lydiatt WM, Abate MP, Schantz SP, Chaganti RS. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Head Neck 1996; 18: 512-21.
25. Mineta H, Borg A, Dictor M, Wahlberg P, Wennerberg J. Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma. Oral Oncol. 1997; 33: 42-6.
26. Michalides RJ, van-Veelen NM, Kristel PM, et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997; 123: 497-502.
27. Fracchiolla NS, Pruneri G, Pignataro L, et al. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage. Cancer 1997; 79: 1114-21.
28. Ng IOL, Lam KY, Ng M, Kwong DLW, Sham JST. Expression of p-glycoprotein, a multidrug-resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma. Cancer 1998; 83: 851-7.